Skip to main content

ClearPoint Neuro, Inc.

corporate_fare Company Profile

ClearPoint Neuro, Inc.

CLPT·NASDAQ·Industrial Applications And Services·CIK 0001285550

We are a commercial-stage medical device company, incorporated in 1998 as a Delaware corporation, that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. Since 1998, we have focused on developing capabilities for magnetic resonance imaging ("MRI") guided interventions, building an intellectual property portfolio, and identifying commercial applications for our technologies. In 2021, our efforts expanded to include the development and commercialization of neurosurgical device products for the operating room setting, as well as consulting services for pharmaceutical companies. In 2025, through our acquisition of IRRAS Holdings, Inc. ("IRRAS"), we expanded our portfolio into neurocritical care. IRRAS is a commercial-stage medical technology company focused on treatments for intracerebral hemorrhage, intraventricular hemorrhage, and other conditions requiring intracranial fluid management. The IRRAS products complement our existing neurosurgical technologies and broaden our reach into acute care settings, enabling us to offer an expanded set of solutions spanning functional neurosurgery, neurocritical care, and intracranial drug delivery. Our business consists of two integrated components: (i) a business providing medical devices for neurosurgical applications, and (ii) a business focused on partnerships in the biologics and drug delivery space. Our primary medical device product is the ClearPoint system, an integrated system comprising hardware components, disposable components, and intuitive, menu-driven software. The ClearPoint system's primary applications are to target and guide: (a) the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters; and (b) the infusion of pharmaceuticals into the brain. The ClearPoint system was originally designed for use in an MRI setting. In 2021, we launched the SmartFrame Array Neuro Navigation System and Software, which allows for operating room placement of the ClearPoint system and completion of the procedure in the MRI suite.

ClearPoint Neuro, Inc. (NASDAQ:CLPT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 18 items for CLPT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-28, rated 7/10. Across its 18 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for CLPT spans 10-Q, 8-K, 144, DEF 14A.

Recent high-impact activity:

  • ClearPoint Q3 Revenue Up 36% to $12.1M, But Net Loss Widens to $7.5M
  • ClearPoint Neuro Q3 Revenue Jumps 36% to $12.1M; 2026 Guidance Set at $48-50M
  • ClearPoint Neuro Q2 Loss Doubles as IRRAS Integration Costs Surge; Cash Burn Accelerates
  • Officer Joseph Burnett Files Intent to Sell Additional $370K in Shares
  • ClearPoint Neuro Officer Joseph Burnett Files Intent to Sell $800K in Shares

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$36.97M
Net Income
-$25.54M
Diluted EPS
-$0.90
Op. Cash Flow
-$23.93M
Free Cash Flow
-$24.45M
Gross Profit
$22.69M
Operating Income
-$24.16M
Cash & Equivalents
$45.92M
Debt / Equity
0.00×
Net Margin
-69.1%
Shares Outstanding
29.37M sh
Source: 10-K · filed 2026-03-17 · accession 0001193125-26-111231

Short Interest & Short Volume

6.56 days to cover

FINRA reported short interest of 4,294,341 shares in CLPT as of the October 30, 2026 settlement, a 7.2% decrease from the prior period — about 6.6 days to cover at its recent average daily volume. On November 20, 2026, 51.1% of CLPT volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,294,341 shares as of October 30, 2026
Change vs prior period▼ 7.2%
Days to cover6.56 at avg daily volume of 654,965
Daily short volume (FINRA facilities)51.1% of 447,999 shares on November 20, 2026
5-day average short volume48.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for CLPT, detected from its recent SEC filings.

ATM program1 shelf registration

New $200M Shelf Registered · $100M ATM Program Established

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with C →
$7.06 +2.17% today
52-week range · as of 2026-10-28 $7.06 – $27.27
Market cap
$221.49M
Volume
1.1M (1.6× avg)
3-mo avg 714.5K
Live data · 2026-11-22 12:38 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CLPT - Latest Insights

CLPT
Oct 28, 2026, 5:25 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.20
Real-time Price: $7.06 info
Change: -$3.14 (-31%) info
Market Cap: $221.495M info
CLPT
Oct 28, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.56
Real-time Price: $7.06 info
Change: -$3.50 (-33%) info
Market Cap: $221.495M info
CLPT
Aug 03, 2026, 5:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.10
Real-time Price: $7.06 info
Change: -$6.04 (-46%) info
Market Cap: $221.495M info
CLPT
Jun 29, 2026, 4:42 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $19.59
Real-time Price: $7.06 info
Change: -$12.53 (-64%) info
Market Cap: $221.495M info
CLPT
Jun 17, 2026, 4:31 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $17.01
Real-time Price: $7.06 info
Change: -$9.95 (-58%) info
Market Cap: $221.495M info
CLPT
May 29, 2026, 5:24 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $12.60
Real-time Price: $7.06 info
Change: -$5.54 (-44%) info
Market Cap: $221.495M info
CLPT
May 27, 2026, 4:30 PM EDT
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $11.50
Real-time Price: $7.06 info
Change: -$4.44 (-39%) info
Market Cap: $221.495M info
CLPT
May 21, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.77
Real-time Price: $7.06 info
Change: -$4.71 (-40%) info
Market Cap: $221.495M info
CLPT
May 13, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $12.53
Real-time Price: $7.06 info
Change: -$5.47 (-44%) info
Market Cap: $221.495M info
CLPT
May 13, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.33
Real-time Price: $7.06 info
Change: -$5.27 (-43%) info
Market Cap: $221.495M info
CLPT
May 13, 2026, 4:00 PM EDT
Source: Access Newswire
Importance Score:
7
Price at Filing: $12.16
Real-time Price: $7.06 info
Change: -$5.10 (-42%) info
Market Cap: $221.495M info
CLPT
Apr 20, 2026, 4:05 PM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $11.19
Real-time Price: $7.06 info
Change: -$4.13 (-37%) info
Market Cap: $221.495M info
CLPT
Apr 10, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $8.68
Real-time Price: $7.06 info
Change: -$1.62 (-19%) info
Market Cap: $221.495M info
CLPT
Mar 17, 2026, 5:21 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $10.80
Real-time Price: $7.06 info
Change: -$3.74 (-35%) info
Market Cap: $221.495M info
CLPT
Mar 17, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.15
Real-time Price: $7.06 info
Change: -$3.09 (-30%) info
Market Cap: $221.495M info
CLPT
Feb 05, 2026, 4:25 PM EST
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $12.45
Real-time Price: $7.06 info
Change: -$5.39 (-43%) info
Market Cap: $221.495M info
CLPT
Jan 14, 2026, 4:05 PM EST
Filing Type: S-3
Importance Score:
8
Price at Filing: $15.35
Real-time Price: $7.06 info
Change: -$8.29 (-54%) info
Market Cap: $221.495M info
CLPT
Jan 12, 2026, 8:31 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $15.70
Real-time Price: $7.06 info
Change: -$8.64 (-55%) info
Market Cap: $221.495M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets